52-Week Performance Chart

Powered by FactSet Research Systems Inc

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Dodge & Cox 11,818,102
PRIMECAP Management Co. 10,382,879
Dimensional Fund Advisors LP 7,576,675
TOP MUTUAL FUND HOLDERS POSITION
Dodge & Cox Stock Fund 9,090,008
Vanguard PRIMECAP Fund 7,394,265
DFA International Core Equity Portfolio 2,448,400

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol NVS
CUSIP 66987V109
DR Venue New York Stock Exchange
DR ISIN US66987V1098
Ratio DR:ORD 1:1
Underlying ISIN CH0012005267
Country Switzerland
Effective Date May 11, 2000
Depositary JPMC (Sponsored)
Industry Pharma. & Biotech.
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 113.49 53,871,822 2,565,325
Mar.25 111.48 53,675,343 2,555,969
Feb.25 109.05 42,600,267 2,242,119

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE